SEP 13, 2020 10:50 AM PDT

Scientists Find Way to Reduce Inflammation from Vaccines

WRITTEN BY: Annie Lennon

Researchers from the University of Chicago have found a new way to reduce vaccine-related inflammation from adjuvants, a key ingredient in modern vaccines that helps create an immuno-response that protects against various diseases. 

While adjuvants are useful for activating inflammatory cytokines that are then able to protect against various diseases, some cause an excessive inflammatory response in the body and are thus difficult to implement in vaccine development. As such, the researchers behind the present study wanted to find a way to limit the possibility of inflammation while still guaranteeing the desired immune response. 

After some searching, they came across a peptide known as SN50, which, as tests demonstrated, had the potential to disrupt pathways in cells that typically lead to excessive inflammation. In particular, this molecule seemed to interrupt a protein called NF-kB, known to produce inflammatory cytokines. Adding the molecule to a range of drugs, they found it was able to reduce inflammation and increase antibodies against various diseases in mouse models. 

In mice with dengue, for example, they found that the molecule helped the body produce more antibodies to neutralize the virus. Meanwhile, in those with HIV, they found it also helped produce more antibodies that targeted hard-to-reach areas of the virus. It was also able to enhance a pre-existing flu vaccine's efficacy. 

The next step for the researchers is to find whether a molecule smaller than a peptide is able to produce the same results. They also want to investigate how such a molecule could aid immunotherapy treatments for cancer and other health conditions. In particular, they say that their research has many implications for how vaccines may be designed in the next 5- 10 years, and could one day aid in the development of vaccines against SARS-CoV-2, especially if it becomes a seasonal threat. 

 

Sources: Neuroscience NewsScience Advances

 

About the Author
Other
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
NOV 28, 2022
Microbiology
A Vaccine to Prevent Urinary Tract Infections is in Development
A Vaccine to Prevent Urinary Tract Infections is in Development
New research has shown that a vaccine for the bacteria commonly associated with urinary tract infections works in animal ...
DEC 21, 2022
Immunology
The Next Generation of Flow Cytometry Controls
The Next Generation of Flow Cytometry Controls
If you work in cell biology or immunology, chances are that you're familiar with flow cytometry. This technique meas ...
DEC 02, 2022
Neuroscience
Scientists Identify Distinct Brain Networks Associated with Risk and Resilience in Depression
Scientists Identify Distinct Brain Networks Associated with Risk and Resilience in Depression
A study published in Brain found a link between the location of brain injury to levels of depression in patients followi ...
DEC 26, 2022
Immunology
An Antibody Successfully Treats Over 70% of Multiple Myeloma Patients in Trial
An Antibody Successfully Treats Over 70% of Multiple Myeloma Patients in Trial
Almost every patient who gets myeloma and is treated with a standard therapy also experiences relapse. But researchers h ...
DEC 27, 2022
Drug Discovery & Development
Blood Pressure Drug and Antioxidant May Treat Long COVID Brain Fog
Blood Pressure Drug and Antioxidant May Treat Long COVID Brain Fog
Two FDA-approved drugs mitigate and may even eliminate brain fog in people with long COVID. The corresponding case repor ...
DEC 27, 2022
Neuroscience
Antidepressants During Pregnancy May Alter Fetal Brain Development
Antidepressants During Pregnancy May Alter Fetal Brain Development
Antidepressant use and infections during pregnancy may increase the risk of neurodevelopmental disorders such as autism ...
Loading Comments...